Maltese V, Gatta E, Facondo P, Anelli V, Cavadini M, Buoso C, Bambini F, Delbarba A, Pirola I, Cappelli C
University of Brescia, Azienda Socio-Sanitaria Territoriale (ASST) Spedali Civili di Brescia, SSD Endocrinologia, Department of Clinical and Experimental Sciences, Brescia, Italy.
Acta Endocrinol (Buchar). 2023 Jan-Mar;19(1):54-58. doi: 10.4183/aeb.2023.54. Epub 2023 Aug 14.
Hypothyroidism and iron deficiency are among the most common pathologies in population. Therefore, there are a lot of patients assuming both iron salt supplements and levothyroxine therapy.
To evaluate the effect of iron salt intake on L-T4 absorption among different L-T4 formulations.
A PubMed/MEDLINE, Web of Science, and Scopus research was performed. Original studies and reviews written in English and published online up to 21 December 2022 were selected and reviewed. The final reference list was defined based on the relevance of each paper to the scope of this review.
The data show an impaired absorption of L-T4 in tablets formulation when taken concomitantly with iron salt supplements. These phenomena seem to be circumvented by new L-T4 formulations.
Liquid L-T4 formulations can be ingested with iron salts, with no impairment of absorption. More studies are necessary to confirm these data for soft-gel capsules L-T4.
甲状腺功能减退和缺铁是人群中最常见的病症。因此,有许多患者同时服用铁盐补充剂和左甲状腺素治疗。
评估不同左甲状腺素制剂中摄入铁盐对左甲状腺素吸收的影响。
进行了PubMed/MEDLINE、科学网和Scopus检索。选择并审查了截至2022年12月21日在线发表的英文原创研究和综述。最终参考文献列表根据每篇论文与本综述范围的相关性确定。
数据显示,与铁盐补充剂同时服用时,片剂剂型的左甲状腺素吸收受损。新的左甲状腺素制剂似乎可以避免这些现象。
液体左甲状腺素制剂可与铁盐一起服用,而不会影响吸收。需要更多研究来证实软胶囊左甲状腺素的这些数据。